U.S. federal trademark · Serial No. 97932034
Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.